Einträge von Hassel, Jessica C auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Anzahl der Einträge: 5.
Becker, Jürgen C, Ugurel, Selma, Leiter, Ulrike, Meier, Friedegund
, Gutzmer, Ralf, Haferkamp, Sebastian, Zimmer, Lisa, Livingstone, Elisabeth, Eigentler, Thomas K
, Hauschild, Axel, Kiecker, Felix, Hassel, Jessica C, Mohr, Peter, Fluck, Michael, Thomas, Ioannis
, Garzarolli, Marlene, Grimmelmann, Imke, Drexler, Konstantin, Spillner, Alexandra N, Eckhardt, Sebastian, Schadendorf, Dirk, van Akkooi, Alexander, van Houdt, Winan, Wilhelm, Tabea, Farmer, Kimberley, Ulrich, Claas, Gambichler, Thilo, Bluhm, Leonie, Schinagl, Heidemarie, Kellner, Ivonne, Herbst, Rudolf, Meiß, Frank, Rafei-Shamsabadi, David, Sell, Sabine, Kaatz, Martin, Wulfken, Lena, Hartmann, Martin, Kähler, Katharina, Ziemer, Mirjana, Simon, Jan, Terheyden, Patrick, Thaci, Diamant, Loquai, Carmen, Mitzel-Rink, Heidrun, Grabbe, Stephan, Stege, Henner, Gaiser, Maria, Utikal, Jochen, Berking, Carola, Heinzerling, Lucie, Schlaak, Max, Tomsitz, Dirk, Dyballa, Jörg, Magnolo, Nina, Weishaupt, Carsten, Berneburg, Mark, Garbe, Claus, Flatz, Lukas, Gesierich, Anja und Schilling, Bastian
(2023)
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
The Lancet 402 (10404), S. 798-808.
Volltext nicht vorhanden.
, Gutzmer, Ralf, Haferkamp, Sebastian, Zimmer, Lisa, Livingstone, Elisabeth, Eigentler, Thomas K
, Hauschild, Axel, Kiecker, Felix, Hassel, Jessica C, Mohr, Peter, Fluck, Michael, Thomas, Ioannis
, Garzarolli, Marlene, Grimmelmann, Imke, Drexler, Konstantin, Spillner, Alexandra N, Eckhardt, Sebastian, Schadendorf, Dirk, van Akkooi, Alexander, van Houdt, Winan, Wilhelm, Tabea, Farmer, Kimberley, Ulrich, Claas, Gambichler, Thilo, Bluhm, Leonie, Schinagl, Heidemarie, Kellner, Ivonne, Herbst, Rudolf, Meiß, Frank, Rafei-Shamsabadi, David, Sell, Sabine, Kaatz, Martin, Wulfken, Lena, Hartmann, Martin, Kähler, Katharina, Ziemer, Mirjana, Simon, Jan, Terheyden, Patrick, Thaci, Diamant, Loquai, Carmen, Mitzel-Rink, Heidrun, Grabbe, Stephan, Stege, Henner, Gaiser, Maria, Utikal, Jochen, Berking, Carola, Heinzerling, Lucie, Schlaak, Max, Tomsitz, Dirk, Dyballa, Jörg, Magnolo, Nina, Weishaupt, Carsten, Berneburg, Mark, Garbe, Claus, Flatz, Lukas, Gesierich, Anja und Schilling, Bastian
(2023)
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
The Lancet 402 (10404), S. 798-808.
Volltext nicht vorhanden.
Haist, Maximilian
, Stege, Henner, Rogall, Friederike, Tan, Yuqi
, von Wasielewski, Imke, Klespe, Kai Christian, Meier, Friedegund
, Mohr, Peter, Kähler, Katharina C, Weichenthal, Michael
, Hauschild, Axel, Schadendorf, Dirk, Ugurel, Selma, Lodde, Georg, Zimmer, Lisa, Gutzmer, Ralf, Debus, Dirk, Schilling, Bastian, Kreuter, Alexander, Ulrich, Jens, Meiss, Frank
, Herbst, Rudolf, Forschner, Andrea, Leiter, Ulrike, Pfoehler, Claudia, Kaatz, Martin, Ziller, Fabian, Hassel, Jessica C, Tronnier, Michael, Sachse, Michael, Dippel, Edgar, Terheyden, Patrick, Berking, Carola, Heppt, Markus V, Kiecker, Felix, Haferkamp, Sebastian, Gebhardt, Christoffer
, Simon, Jan Christoph, Grabbe, Stephan und Loquai, Carmen
(2023)
Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Journal for ImmunoTherapy of Cancer 11 (9), e007630.
Volltext nicht vorhanden.
, Stege, Henner, Rogall, Friederike, Tan, Yuqi
, von Wasielewski, Imke, Klespe, Kai Christian, Meier, Friedegund
, Mohr, Peter, Kähler, Katharina C, Weichenthal, Michael
, Hauschild, Axel, Schadendorf, Dirk, Ugurel, Selma, Lodde, Georg, Zimmer, Lisa, Gutzmer, Ralf, Debus, Dirk, Schilling, Bastian, Kreuter, Alexander, Ulrich, Jens, Meiss, Frank
, Herbst, Rudolf, Forschner, Andrea, Leiter, Ulrike, Pfoehler, Claudia, Kaatz, Martin, Ziller, Fabian, Hassel, Jessica C, Tronnier, Michael, Sachse, Michael, Dippel, Edgar, Terheyden, Patrick, Berking, Carola, Heppt, Markus V, Kiecker, Felix, Haferkamp, Sebastian, Gebhardt, Christoffer
, Simon, Jan Christoph, Grabbe, Stephan und Loquai, Carmen
(2023)
Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Journal for ImmunoTherapy of Cancer 11 (9), e007630.
Volltext nicht vorhanden.
Spassova, Ivelina
, Ugurel, Selma
, Kubat, Linda, Zimmer, Lisa
, Terheyden, Patrick, Mohr, Annalena, Björn Andtback, Hannah, Villabona, Lisa, Leiter, Ulrike, Eigentler, Thomas
, Loquai, Carmen, Hassel, Jessica C, Gambichler, Thilo, Haferkamp, Sebastian, Mohr, Peter, Pfoehler, Claudia, Heinzerling, Lucie, Gutzmer, Ralf, Utikal, Jochen S, Horny, Kai
, Schildhaus, Hans-Ulrich, Habermann, Daniel
, Hoffmann, Daniel
, Schadendorf, Dirk und Becker, Jürgen Christian
(2022)
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.
Journal for ImmunoTherapy of Cancer 10 (1), e003198.
Volltext nicht vorhanden.
, Ugurel, Selma
, Kubat, Linda, Zimmer, Lisa
, Terheyden, Patrick, Mohr, Annalena, Björn Andtback, Hannah, Villabona, Lisa, Leiter, Ulrike, Eigentler, Thomas
, Loquai, Carmen, Hassel, Jessica C, Gambichler, Thilo, Haferkamp, Sebastian, Mohr, Peter, Pfoehler, Claudia, Heinzerling, Lucie, Gutzmer, Ralf, Utikal, Jochen S, Horny, Kai
, Schildhaus, Hans-Ulrich, Habermann, Daniel
, Hoffmann, Daniel
, Schadendorf, Dirk und Becker, Jürgen Christian
(2022)
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.
Journal for ImmunoTherapy of Cancer 10 (1), e003198.
Volltext nicht vorhanden.
Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus und Zimmer, Lisa
(2020)
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
Journal for ImmunoTherapy of Cancer 8 (1), e000333.
Volltext nicht vorhanden.
Leiter, Ulrike, Loquai, Carmen, Reinhardt, Lydia, Rafei-Shamsabadi, David
, Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C, Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rübben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jürgen Christian und Ugurel, Selma
(2020)
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.
Journal for ImmunoTherapy of Cancer 8 (2), e000897.
Volltext nicht vorhanden.
, Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C, Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rübben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jürgen Christian und Ugurel, Selma
(2020)
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.
Journal for ImmunoTherapy of Cancer 8 (2), e000897.
Volltext nicht vorhanden.
